What are the treatment options for conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Conjunctivitis

Immediate Classification and Treatment Algorithm

Treatment must be tailored to the specific type of conjunctivitis—bacterial, viral, allergic, or sexually transmitted—with bacterial cases requiring antibiotics only for moderate-to-severe disease, viral cases needing supportive care alone, and allergic cases responding to topical antihistamines with mast cell stabilization. 1, 2

Step 1: Identify the Type Based on Clinical Presentation

Bacterial Conjunctivitis:

  • Yellow crusting around the eyes strongly indicates bacterial infection 1, 3
  • Bilateral mucopurulent discharge with eyelids matted shut on waking 1, 4
  • Lack of itching and no history of prior conjunctivitis 5

Viral Conjunctivitis:

  • Watery discharge without significant crusting 4
  • Often unilateral initially, may become bilateral 1
  • Variable presentation at onset 5

Allergic Conjunctivitis:

  • Severe itching is the hallmark symptom 1, 6
  • Watery discharge with bilateral involvement 4
  • History of allergen exposure 6

Sexually Transmitted (Gonococcal/Chlamydial):

  • Severe, bilateral purulent discharge in sexually active adults 6
  • Requires immediate systemic treatment 1, 2

Treatment by Type

Bacterial Conjunctivitis

Mild Cases:

  • No antibiotics needed—mild bacterial conjunctivitis is self-limited and resolves spontaneously in immunocompetent adults within 1-2 weeks 1, 5

Moderate-to-Severe Cases:

  • Prescribe moxifloxacin 0.5% ophthalmic solution three times daily for 5-7 days 1, 3
  • Alternative fluoroquinolones or aminoglycosides if moxifloxacin unavailable 3
  • Moxifloxacin achieves clinical cure rates of 66-69% by day 5-6 and microbiological eradication rates of 84-94% 7
  • Before applying medication, clean eyelids and lashes with warm water and gentle soap to remove crusts 1, 3
  • Instruct patients to return if no improvement after 3-4 days 1, 2
  • Complete resolution typically occurs within 7-10 days 3

Common Pitfall: Avoid indiscriminate antibiotic use in mild cases, as most resolve without treatment and unnecessary antibiotics increase resistance risk 1, 2


Viral Conjunctivitis

Supportive Care Only:

  • Cold compresses and refrigerated artificial tears for symptom relief 1, 4
  • Topical antihistamines may provide additional comfort 4
  • Instruct patients to return only if symptoms persist beyond 2-3 weeks 1

Critical Warning: Never use topical corticosteroids—they prolong adenoviral infections and worsen HSV infections 1, 2

Infection Control:

  • Strict hand hygiene is essential to prevent transmission 3, 4
  • Avoid sharing towels, pillows, or cosmetics 2

Gonococcal Conjunctivitis

Requires Aggressive Systemic Treatment:

  • Systemic antibiotics are mandatory—topical treatment alone is insufficient 1, 2
  • Saline lavage promotes comfort and faster resolution 1
  • Daily follow-up until complete resolution 1, 2
  • Treat sexual contacts concurrently and screen for other sexually transmitted infections 1, 2
  • Hospitalization may be necessary for severe cases and is mandatory for neonatal conjunctivitis 1, 2

Chlamydial Conjunctivitis

Systemic Antibiotics Required:

  • Systemic therapy is essential because >50% of patients have infection at other sites 1, 2
  • Treat sexual contacts concurrently 1, 2
  • Re-evaluate after treatment due to potential treatment failure rates up to 19% 1
  • In resource-limited settings, povidone-iodine 1.25% ophthalmic solution can be considered 2

Allergic Conjunctivitis

First-Line Treatment:

  • Topical antihistamines with mast cell-stabilizing properties are the treatment of choice for both acute and chronic cases 1, 2, 4
  • Simple measures: sunglasses as barriers to airborne allergens, cold compresses, refrigerated artificial tears 1, 2

Persistent or Recurrent Cases:

  • Mast cell stabilizers like cromolyn sodium for long-term control 1, 2

Severe Cases:

  • Brief course (1-2 weeks) of topical corticosteroids with low side-effect profile (fluorometholone, loteprednol, or rimexolone) 1, 2
  • Monitor intraocular pressure and check for cataracts periodically during corticosteroid use 1
  • Taper corticosteroids once inflammation is controlled 1

Common Pitfall: Avoid oral antihistamines—they may worsen dry eye syndrome and impair the tear film's protective barrier 1


Special Populations and Situations

Contact Lens Wearers

  • Discontinue contact lens wear immediately until the cornea returns to normal 1, 2
  • Consider topical corticosteroids (1-2 weeks) plus longer-term cyclosporine 0.05% 1
  • For giant papillary conjunctivitis: replace lenses more frequently, decrease wearing time, use preservative-free solutions, or switch to daily disposables 1

Elderly Patients

  • Higher risk for complications due to age-related immune changes 3
  • Monitor for giant fornix syndrome and nasolacrimal duct obstruction 3
  • Consider MRSA if symptoms persist despite appropriate therapy 3

When to Refer to Ophthalmology Immediately

Immediate referral is mandatory for: 1, 2

  • Visual loss
  • Moderate or severe pain
  • Severe purulent discharge
  • Corneal involvement
  • Conjunctival scarring
  • Lack of response to therapy after 3-4 days
  • Recurrent episodes
  • History of HSV eye disease
  • Immunocompromised patients

Critical Warnings

Avoid these common errors:

  • Never use topical corticosteroids for viral conjunctivitis—they prolong adenoviral infections and worsen HSV 1, 2
  • Chronic vasoconstrictor use causes rebound vasodilation 1
  • Always identify and treat sexual contacts in gonococcal/chlamydial cases 1, 2
  • Do not prescribe antibiotics for mild bacterial conjunctivitis—most cases are self-limited 1, 5

References

Guideline

Treatment of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Research

Conjunctivitis.

American family physician, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.